CRISPR-Cas13bt3 System Effectively Silences VEGFA in Retinal Cells
A CRISPR-Cas13bt3 system, delivered via AAV, significantly reduced VEGFA mRNA and protein expression in human retinal organoids and VEGF-transgenic mouse models.
© Copyright 2025. All Rights Reserved by MedPath